Table 1 Characteristics of participants
Characteristic (n = 49) | Value |
|---|---|
Age in years (mean; SD) | 48.6 ± 9.5 |
Race (n, %) | Â |
—Caucasian | 44(88) |
—Asian | 3(6) |
—African | 1(2) |
—Asian Pacific Islander | 1(2) |
Anthropometric | (mean; SD) |
Height (m) | 1.65 ± 0.07 |
BMI (kgm-2) | 26.6 ± 4 |
Body mass (kg) | 73.1 ± 13.8 |
LBM (kg) | 43.6 ± 5.6 |
Body fat % | 39.5 ± 6.9 |
Waist (cm) | 85.4 ± 11.1 |
Hip Girth (cm) | 106.3 ± 9.2 |
CRP (n = 45; med; range)* | (0.1–10.1) |
Total % RBC n-3 (n = 43)* | 5.9 ± 1.6 |
% EPA | 1.1 ± 0.5 |
% DHA | 2.9 ± 0.9 |
Charaterstic of Disease (n; %) | Â |
0-I | 13 (26) |
IIa | 19 (28) |
IIb-IIIa | 17 (34) |
Estrogen receptor + ve | 39 (78) |
HER-2 receptor + ve | 12 (24) |
Treatment variables (n; %) | Â |
Had Chemotherapy | 41 (92) |
Taxane – Yes | 37 (74) |
Radiation therapy | Â |
Tamoxifen | 13 (26) |
AI | 20 (40) |
None | 16 (32) |
Time since completion Rx | 165 ± 107 |